OMDA (Omada Health) Research & Development: $44.6 Mil (TTM As of Mar. 2026)


OMDA Omada Health Inc OMDA
12 GF Score
Price $21.49
! 1 Warning Sign
View Full Analysis

What is Omada Health Research & Development?

Omada Health OMDA +2.85% 12 Research & Development is $44.6 Mil as of Mar. 2026. GuruFocus rates OMDA with a GF Score™ of 12/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Omada Health's Research & Development for the three months ended in Mar. 2026 was $12.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $44.6 Mil.

Omada Health  (NAS:OMDA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Omada Health Research & Development Related Terms

Omada Health Research & Development Historical Data

* Premium members only.

The historical data trend for Omada Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omada Health Research & Development Chart

Omada Health Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
26.17 33.74 35.92 40.68

Omada Health Quarterly Data
Dec12 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.81 10.02 10.30 11.55 12.70
OMDA
12GF Score
Omada Health Inc OMDA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omada Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $44.6 Mil mean?
Omada Health (OMDA) has a Research & Development of $44.6 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Omada Health and its competitors.
Is Omada Health's Research & Development too high?
Omada Health's current Research & Development is $44.6 Mil. Overall, Omada Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Omada Health's Research & Development compare to SDGR and TDOC?
Omada Health's Research & Development of $44.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Omada Health and its competitors. Omada Health's current Research & Development is $44.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omada Health stock overvalued right now?
Omada Health (OMDA) has a current Research & Development of $44.6 Mil. The current Research & Development is $44.6 Mil. Omada Health's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Omada Health (OMDA), the current Research & Development is $44.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Omada Health Business Description

Other Exchanges U76:Germany
Address 611 Gateway Boulevard, Suite 120, South San Francisco, CA, USA, 94080
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
12GF Score

Get the complete analysis for OMDA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.49
Price